Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Category list : England NHS structures

Sort by: Newest first Oldest first A-Z Z-A

  • NHS England pulling the plug on PrEP for HIV prevention is unacceptable Subscription

    23 MAR 2016 16:36 By Ian Green

    I wish to draw your attention to NHS England’s sudden abandonment of its own processes in a shocking U-turn on access to HIV game changer pre-exposure prophylaxis (PrEP; emtricitabine/tenofovir, marketed as Truvada).

  • Flawed decision from NHS England on pre-exposure prophylaxis (PrEP) for HIV prevention Subscription

    23 MAR 2016 15:24 By Deborah Gold

    Like the countless people affected by HIV in the UK, we are angry and confused by the decision of NHS England to halt its work to ensure that pre-exposure prophylaxis (PrEP; (emtricitabine/tenofovir, marketed as Truvada), which drastically reduces the chance of infection with HIV, is available on the NHS. We know that PrEP is efficient and cost-effective and we share the frustration that NHS England has pulled the plug on more than 18 months of hard work.

  • Simon Stevens, chief executive of NHS England

    ‘World’s largest healthcare incentive scheme’ launched to cut inappropriate antibiotic prescribing Subscription

    16 MAR 2016 13:20
    Comments (1)

    An incentive scheme to reward hospitals and GP practices that reduce their antibiotic prescribing has been launched by NHS England.

  • Close up of meningococcal septicaemia rash

    Meningitis B vaccine: basing decisions on evidence not emotions Subscription

    3 MAR 2016 16:30
    Comments (1)

    Public opinion should be listened to when it comes to healthcare policies, but must not influence methodological, evidence-based decision making.

  • Pharmacists’ role in optimising the use of medicines in those with learning disabilities Subscription

    2 MAR 2016 11:33 By Danielle Adams

    Following on from the response to the Winterbourne View Hospital scandal, where it was discovered many patients suffered serious abuse, the re-evaluation of antipsychotic use in people with learning disabilities has begun, with three separate reports commissioned by NHS England plus a study by Sheehan et al published in The BMJ in September 2015 (

  • Consultation on new products for specialised services Subscription

    1 MAR 2016 10:45

    NHS England has launched a public consultation on a proposed number of new products for specialised services, including fampridine for multiple sclerosis in adult patients and ziconotide for chronic refractory cancer pain. The consultation is available from the NHS England website until 27 March 2016.

  • The assault on community pharmacy by the government must be stopped Subscription

    16 FEB 2016 10:05 By Graham Phillips

    Just before Christmas, I was appalled at the fait accompli decision announced with such callous disregard for our profession to slash the funding of community pharmacy by £170m (6%) in 2016–2017. As the funding reduction will not kick in until September 2016, this effectively means pharmacies will see a net 12% reduction in their NHS income in the second half of the financial year. Alistair Burt, the pharmacy minister, announced the government’s intention ...

  • We need more clinical roles beyond working in GP practices Subscription

    9 FEB 2016 12:33 By Joseph Anthony Schofield

    I have for some time been observing with interest since the announcement of the new pilot of pharmacists working in GP surgeries and the Royal Pharmaceutical Society’s (RPS) push for this role to grow. I believe the introduction of pharmacists working in GP surgeries is a development from the 1990s. It is not new. I was one of the first so to do rationalising asthma therapy, conducting benzodiazepine reduction clinics and developing formularies with GP practices. Savings made by rationalising ..

  • It revealed that funding for the pharmacy sector in England in 2016–2017 is set to be cut from £2.8bn to £2.63bn, a reduction of £170m (more than 6%). In the image, close-up of a surgical scalpel

    No rationale behind cuts to community pharmacy funding Subscription

    20 JAN 2016 15:22
    Comments (3)

    The impact of 6% pharmacy funding cuts as part of efficiency savings has not been considered and pharmacy professional bodies must campaign against it.

  • Antimicrobial resistance resources Subscription

    8 JAN 2016 9:41

    Health Education England, together with Public Health England and NHS England, has produced e-learning resources to help healthcare staff understand the threats posed by antimicrobial resistance. The e-learning programme is available on the e-Learning for Healthcare website. 

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.